Loading...
Loading...
Among the 5 tracked institutional investors we monitor, CUE1EUR (CUE BIOPHARMA INC) is held with a combined value of $1.12M across 3,869,076 shares. The largest holder is VANGUARD GROUP INC with a position worth $919.28K (0.00% of their portfolio). 2 funds opened new positions in the most recent quarter. 2 funds reduced their position.
Total Institutional Value
$1.12M
Total Shares Held
3,869,076
Institutional Holders
5
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $919.28K | 0.00% | New |
| 2 | BlackRock, Inc. | $103.26K | 0.00% | -0.0% |
| 3 | RENAISSANCE TECHNOLOGIES LLC | $49.16K | 0.00% | -10.3% |
| 4 | STATE STREET CORP | $41.23K | 0.00% | - |
| 5 | CITADEL ADVISORS LLC | $2.92K | 0.00% | New |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of CUE1EUR with a position worth $919.28K, representing 0.00% of their portfolio. In total, 5 institutional investors hold CUE1EUR with a combined value of $1.12M.
In the most recent quarter, 2 funds opened a new position in CUE1EUR. Additionally, 2 reduced their positions.
Institutional investors hold $1.12M worth of CUE1EUR stock across 5 positions. The largest institutional holder is VANGUARD GROUP INC with $919.28K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For CUE1EUR, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their CUE1EUR positions.